Bjorkquist Jeanette M
Transaction: 06/17/2026
SELL
Change
-29
Price
$23.25
Filing
06/18/2026
Type
SELL
Assembly Biosciences, Inc.
ASMB • Biotechnology
$36.60
▲ +0.47 (+1.30%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$690.04M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 38.9%Manageable debt level · 0.01Healthy liquidity · 5.22Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$36.60
Change1.30%
Shares Out18.85M
Market Cap$690.04M
Enterprise Value$372.03M
52W Range20.23 - 39.71
Beta1.09
P/E-16,429.61
P/S11.23
P/B2.26
P/FCF-17.89
EV/Sales6.05
Price$36.60
Change1.30%
Shares Out18.85M
Market Cap$690.04M
Enterprise Value$372.03M
52W Range20.23 - 39.71
Beta1.09
P/E-16,429.61
P/S11.23
P/B2.26
P/FCF-17.89
EV/Sales6.05
EV/EBITDA-52.79
EV/FCF-9.65
Earnings Yield-0.01%
FCF Yield-5.59%
Dividend Yield0.00%
Gross Margin99.82%
Oper. Margin-16.76%
Profit Margin-8.47%
Debt/Eq0.01
Current Ratio5.22
Quick Ratio5.22
Target$51.67
Target Upside41.17%
Target Median$52.00
Target Range50.00 - 53.00
Volume215.01K
Avg Volume200.99K
EPS Surprise0.19
Investment DNA
How strong this company looks for long-term investors
54
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Positive revenue growth · 38.9%Manageable debt level · 0.01Healthy liquidity · 5.22Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
77/100
Bullish
Bullish
6
Hold
5
Bearish
0
Price Target
2026-08-21
Low
$45.00
Mean
$47.50
Median
$47.50
High
$50.00
Insider Transactions
Recent executive and insider activity
ALTIG ANTHONY E
Transaction: 06/04/2026
BUY
Change
+8,000
Price
$24.11
Filing
06/05/2026
Type
BUY
Consylman Gina
Transaction: 06/04/2026
BUY
Change
+8,000
Price
$24.11
Filing
06/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bjorkquist Jeanette M | SELL | -29 | $23.25 | 06/17/2026 | 06/18/2026 |
| ALTIG ANTHONY E | BUY | +8,000 | $24.11 | 06/04/2026 | 06/05/2026 |
| Consylman Gina | BUY | +8,000 | $24.11 | 06/04/2026 | 06/05/2026 |
| Houghton Michael | BUY | +8,000 | $24.11 | 06/04/2026 | 06/05/2026 |
| Johnson-Pratt Lisa | BUY | +8,000 | $24.11 | 06/04/2026 | 06/05/2026 |
| Mahony Susan | BUY | +8,000 | $24.11 | 06/04/2026 | 06/05/2026 |
| McHutchison John G | BUY | +8,000 | $24.11 | 06/04/2026 | 06/05/2026 |
| Okazaki Jason A | BUY | +50,750 | Not reported | 03/29/2026 | 06/05/2026 |
| Delaney William E IV | BUY | +14,000 | Not reported | 03/29/2026 | 06/05/2026 |
| Bjorkquist Jeanette M | BUY | +3,500 | Not reported | 03/29/2026 | 06/05/2026 |
| White Nicole S | BUY | +14,000 | Not reported | 03/29/2026 | 06/05/2026 |
| Gaggar Anuj | BUY | +14,000 | Not reported | 03/29/2026 | 06/05/2026 |
| GILEAD SCIENCES, INC. | BUY | +471,698 | $26.50 | 05/26/2026 | 05/27/2026 |
| White Nicole S | SELL | -9 | $27.49 | 03/30/2026 | 03/31/2026 |
| Bjorkquist Jeanette M | SELL | -16 | $27.49 | 03/30/2026 | 03/31/2026 |
| Okazaki Jason A | BUY | +94,250 | Not reported | 03/29/2026 | 03/31/2026 |
| Delaney William E IV | BUY | +26,000 | Not reported | 03/29/2026 | 03/31/2026 |
| Gaggar Anuj | BUY | +26,000 | Not reported | 03/29/2026 | 03/31/2026 |
| White Nicole S | BUY | +26,000 | Not reported | 03/29/2026 | 03/31/2026 |
| Bjorkquist Jeanette M | BUY | +6,500 | Not reported | 03/29/2026 | 03/31/2026 |